Status:

UNKNOWN

Post Stroke Epileptic Seizures Risk Forecast

Lead Sponsor:

Lviv National Medical University

Conditions:

Stroke

Post Stroke Seizure

Eligibility:

All Genders

18+ years

Brief Summary

Improve the effectiveness of treatment and prognosis in patients with cerebrovascular accident by early detection of the risk of developing epileptic seizures.

Eligibility Criteria

Inclusion

  • informed consent to participate in the study signed by the patient / relative of the patient / the legal representative of the patient
  • age over 18 years
  • stroke, confirmed by neuroimaging
  • light to moderate stroke (score on National Institutes of Health Stroke Scale).

Exclusion

  • recanalization therapy
  • previous epileptic seizures and history of epilepsy
  • psychiatric diseases in history
  • previous stroke
  • traumatic brain injury
  • brain tumors.
  • inflammatory and infectious diseases
  • decompensated physical illness.
  • pregnancy.

Key Trial Info

Start Date :

February 20 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 31 2022

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03848273

Start Date

February 20 2019

End Date

August 31 2022

Last Update

February 20 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Danylo Halytsky Lviv National Medical University

Lviv, Ukraine, 79010